Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

ClinicalTrials.gov ID: NCT03178487

Public ClinicalTrials.gov record NCT03178487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 8:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Upadacitinib in Subjects With Active Ankylosing Spondylitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of upadacitinib in participants with active ankylosing spondylitis (AS) who have had an inadequate response to at least 2 non-steroidal anti-inflammatory drugs (NSAIDs) or intolerance to or a contraindication for NSAIDs, and who are naïve to biologic disease-modifying anti-rheumatic drugs (bDMARD).

Study identification

NCT ID
NCT03178487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AbbVie
Industry
Enrollment
187 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2017 (Actual)
Primary completion
Jan 21, 2019 (Actual)
Completion
Feb 17, 2022 (Actual)
Last update posted
Mar 7, 2023

2017 – 2022

United States locations

U.S. sites
22
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Arizona Arthritis & Rheumatolo /ID# 164446 Phoenix Arizona 85032-9306 —
AZ Arthritis and Rheumotology Research, PLLC /ID# 165705 Phoenix Arizona 85032-9306 —
David S. Hallegua MD /ID# 165090 Beverly Hills California 90211 —
Covina Arthritis Clinic /ID# 165061 Covina California 91722 —
St. Joseph Health System /ID# 166166 Fullerton California 92835 —
Global Research Foundation /ID# 165130 Los Angeles California 90041 —
Rheumatology Center of San Diego /ID# 166167 San Diego California 92128-2549 —
Colorado Arthritis Associates /ID# 164444 Lakewood Colorado 80228 —
Bay Area Arthritis and Osteo /ID# 165023 Brandon Florida 33511 —
LeJenue Research Associates /ID# 165202 Miami Florida 33126 —
HMD Research LLC /ID# 205172 Orlando Florida 32819 —
St. Lukes Clinic /ID# 165827 Meridian Idaho 83642 —
Clinical Investigation Specialists - Skokie /ID# 164385 Skokie Illinois 60076 —
Henry Ford Health System /ID# 165515 Detroit Michigan 48202 —
Aa Mrc Llc /Id# 165100 Grand Blanc Michigan 48439 —
St. Lawrence Health System /ID# 165025 Potsdam New York 13676 —
DJL Clinical Research, PLLC /ID# 165044 Charlotte North Carolina 28210-8508 —
Altoona Ctr Clinical Res /ID# 164470 Duncansville Pennsylvania 16635 —
Clinical Research Ctr Reading /ID# 164876 Wyomissing Pennsylvania 19610 —
Comprehensive Arthritis Care, a division of Comprehensive Rheumatology Care PLLC /ID# 168107 Hendersonville Tennessee 37075-6213 —
Diagnostic Group Integrated He /ID# 165195 Beaumont Texas 77701 —
Arth and Osteo Clin Brazo Valley /ID# 165194 College Station Texas 77845 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03178487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2023 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03178487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →